Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer
Clinical trial NCT06727227 · RECRUITING
Trial details
- NCT number
- NCT06727227
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-29
- Primary completion
- 2027-10-31
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.